반응식
Cl.[N:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[CH:16]=[CH:15][C:11]([C:12]([OH:14])=O)=[CH:10][CH:9]=1.Cl.[Cl:18][C:19]1[CH:35]=[CH:34][C:22](/[CH:23]=[CH:24]/[S:25]([N:28]2[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]2)(=[O:27])=[O:26])=[CH:21][CH:20]=1>>[ClH:18].[Cl:18][C:19]1[CH:20]=[CH:21][C:22](/[CH:23]=[CH:24]/[S:25]([N:28]2[CH2:33][CH2:32][N:31]([C:12](=[O:14])[C:11]3[CH:10]=[CH:9][C:8]([C:3]4[CH:4]=[CH:5][CH:6]=[CH:7][N:2]=4)=[CH:16][CH:15]=3)[CH2:30][CH2:29]2)(=[O:26])=[O:27])=[CH:34][CH:35]=1참가 물질
3
실험 절차
In the same manner as in Example A-17, a reaction was conducted using 4-(2-pyridyl)benzoic acid hydrochloride and 1-[(E)-4-chlorostyrylsulfonyl]piperazine hydrochloride as starting materials, whereby the title compound was obtained.
출처 및 근거
- ORD 기록
- ord-392cbebe191d4c4da976e4070042d501
- 출처 데이터셋
- uspto-grants-2004_06
- 특허 번호
- US06747023B1
연결된 노트
불러오는 중…